<DOC>
	<DOCNO>NCT00698035</DOCNO>
	<brief_summary>The purpose clinical research study determine whether ESTRING special preparation testosterone cream insert vaginally safe use breast cancer patient . This study also evaluate either treatment improve symptom vaginal dryness decrease sexual interest relate treatment breast cancer .</brief_summary>
	<brief_title>Vaginal Testosterone Cream v ESTRING Vaginal Dryness Decreased Libido Early Stage Breast Cancer Patients</brief_title>
	<detailed_description>There grow body scientific literature suggest sexual function one distressing problem experience breast cancer survivor . Vaginal dryness , dyspareunia ( pain sexual intercourse ) , decrease libido common complaint among breast cancer patient . With increase use aromatase inhibitor associate high rate vaginal dryness tamoxifen , problem become even prominent . This study evaluate safety tolerability ESTRING 1 % testosterone cream administer vaginally treatment vaginal dryness and/or decrease libido woman receive aromatase inhibitor early stage breast cancer .</detailed_description>
	<mesh_term>Sexual Dysfunction , Physiological</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<criteria>1 . Histologically cytologically confirm Stage IIII breast cancer take aromatase inhibitor adjuvant hormonal therapy . Patient must start aromatase inhibitor least 60 day prior enrol . 2 . Postmenopausal estradiol level baseline measure standard laboratory analysis . Patient may render postmenopausal use GnRH agonist , must confirm postmenopausal level serum estradiol two lab test least one month apart . If patient render postmenopausal adjuvant chemotherapy period within past 12 month , postmenopausal level serum estradiol must document two lab test least 3 month apart . 3 . Age ≥18 ≤80 year old . 4 . ECOG ≤1 5 . Adequate hematologic , hepatic , renal function define : Hgb ≥9 g/dL Absolute neutrophil count ( ANC ) /absolute granulocyte count ( AGC ) ≥1500 cells/mm3 Platelet count ≥100,000/mm3 Serum creatinine ≤1.5 mg/dL Total bilirubin ≤1.5 time ULN ; aspartate aminotransferase ≤3 time ULN 6 . Normal thyroid function test within past 6 month ( Patients diagnosis hypothyroidism thyroid supplementation must thyroid function test normal range within past 3 month ) 7 . Patient must recover side effect previous chemotherapy , surgery , radiation therapy early breast cancer . 1 . History radiation vaginal area 2 . Concurrent treatment type oral , injectable topical form estrogen androgen therapy include natural supplement market hormone replacement product 3 . Initiation topical moisturizers ( example , Replens ) , herbal alternative medicine manage symptom vaginal dryness study . Patients previously use product may continue usage pattern study . 4 . Use vaginal hormonal product ( ring , insert , cream , gel ) contain estrogen androgen within past 30 day . 5 . History abnormal pap smear within last 12 month 6 . History endometrial ovarian cancer 7 . Any episode vaginal bleeding past 6 month evaluate gynecological exam and/or pelvic ultrasound 8 . History sexual dysfunction prior diagnosis breast cancer ( Sexual dysfunction define loss libido inability achieve orgasm patient seek medical attention patient felt significantly interfere quality life . ) 9 . Moderate severe depression patient receive ongoing psychological counseling and/or take antidepressant , , investigator opinion may interfere patient sexual function independent side effect breast cancer aromatase inhibitor use . 10 . Use investigational agent breast cancer within 3 week study entry .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Vaginal Testosterone Cream</keyword>
	<keyword>ESTRING</keyword>
</DOC>